Skip to Content

Join the 'Victoza' group to help and get support from people like you.

Victoza News

Flu Shot Key for People With Diabetes

Posted 8 Oct 2017 by Drugs.com

SUNDAY, Oct. 8, 2017 – With predictions calling for a potentially bad flu season this year, doctors are urging people – particularly those with diabetes – to get vaccinated. Many people with diabetes don't get a seasonal flu shot each year, according to the American Association of Diabetes Educators (AADE). Some people with the blood sugar disease don't realize they're at risk for flu-related complications. Others have misguided fears that the shot will trigger an adverse reaction, the group explained. However, people with diabetes are more likely to develop serious flu-related health problems if they get the virus, the AADE cautioned. The group said the flu shot is a safe and effective way to prevent or reduce the severity of these complications. "Reducing risks is one of the AADE's seven key self-care behaviors for managing diabetes, and getting the flu shot every fall is an ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Saxenda, Diabetes, Type 1, Glipizide, Novolog, Januvia, Insulin Resistance, Humalog, Glucophage, Bydureon, Invokana, Janumet, Trulicity, Glyburide, Byetta, Lantus Solostar

Victoza (liraglutide) is Approved to Reduce the Risk of Three Major Adverse Cardiovascular Events in Type 2 Diabetes Patients

Posted 27 Aug 2017 by Drugs.com

PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events, heart attack, stroke and CV death, in adults with type 2 diabetes and established CV disease.1 The FDA's decision is based on the results from the landmark LEADER trial, which demonstrated that Victoza significantly reduced the risk of a three component endpoint consisting of cardiovascular death, non-fatal heart attack or non-fatal stroke by 13% vs placebo (p=0.01) with an absolute risk reduction (ARR) of 1.9%.1 "Physicians have come to rely on Victoza as an effective therapy for lowering A1C, and with this new indication, they now have the option to choose a diabetes medication that also reduces their patient's cardiovascular risk," said Anne Phillips, Senior Vice President, ... Read more

Related support groups: Diabetes, Type 2, Heart Attack, Victoza, Liraglutide, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction

Heart Health Ignored by Many With Type 2 Diabetes

Posted 8 Aug 2017 by Drugs.com

TUESDAY, Aug. 8, 2017 – Taking steps to prevent heart disease is crucial for people with type 2 diabetes. But most diabetic adults in the United States aren't meeting recommended guidelines, health officials say. In a new report, researchers confirm that "cardiovascular risk reduction is critically important for the care of patients with diabetes, with or without known [heart disease or heart disease] risk factors." Drugs such as cholesterol-lowering statins, aspirin and blood sugar-lowering medications plus lifestyle approaches should be considered for all type 2 diabetes patients, according to the Aug. 7 report in the Journal of the American College of Cardiology. Suggested lifestyle approaches include exercise, good nutrition and weight management. For the report, researchers from New York University Medical Center examined evidence behind the guidelines for preventing heart disease ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Heart Disease, Victoza, Lantus, Saxenda, Glipizide, Novolog, Januvia, Humalog, Glucophage, Bydureon, Invokana, Trulicity, Janumet, Glyburide, Byetta, Lantus Solostar, Levemir

Online Game Helps Those With Diabetes Control Blood Sugar

Posted 8 Aug 2017 by Drugs.com

TUESDAY, Aug. 8, 2017 – Here's another example of technology's evolving impact on health care. A new study found that playing an online game can help those with diabetes get better control of their blood sugar. The study included 456 U.S. Veterans Affairs diabetes patients with poor blood sugar control while on oral medications. Half played a specially designed, team-based online diabetes education game for six months. The others were assigned to a control group that played a civics education game. "This [diabetes control] game represents a small time commitment for patients, but potentially a big impact for their health," corresponding author Dr. B. Price Kerfoot said in a news release from Brigham and Women's Hospital in Boston. He is an associate professor of surgery at the hospital. The diabetes game features multiple choice questions about blood sugar control, exercise, long-term ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Saxenda, Diabetes, Type 1, Glipizide, Novolog, Januvia, Hypoglycemia, Insulin Resistance, Humalog, Glucophage, Bydureon, Invokana, Trulicity, Janumet, Glyburide, Byetta

Novo Nordisk Receives FDA Approval for Xultophy 100/3.6 (insulin degludec and liraglutide injection) for Type 2 Diabetes

Posted 22 Nov 2016 by Drugs.com

PLAINSBORO, N.J., Nov. 21, 2016 /PRNewswire/ – Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application for Xultophy 100/3.6 (insulin degludec 100 units/mL and liraglutide 3.6 mg/mL injection). Xultophy 100/3.6 is a once-daily, combination of Tresiba (insulin degludec injection) and Victoza (liraglutide) injection indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes inadequately controlled on less than 50 units of basal insulin daily or less than or equal to 1.8 mg of liraglutide daily.1 Xultophy 100/3.6 enters into a new class of diabetes treatments that combine a basal insulin and a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in a single, once-daily injection. "Novo Nordisk is committed to discovering and developing new medicines, like ... Read more

Related support groups: Diabetes, Type 2, Victoza, Liraglutide, Tresiba, Insulin Degludec, Xultophy 100/3.6, Insulin Degludec/liraglutide

Intensive Type 2 Diabetes Treatment Can Extend Survival: Study

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report. People who were already at risk of type 2 diabetes complications were randomly selected to continue with their normal treatment or to be placed in an aggressive and multipronged treatment group. Two decades after the study began, the researchers found that people in the aggressive treatment group lived almost eight years longer. Not only that, they lived better – their risk of heart disease, kidney disease and blindness all dropped. The only complication that didn't seem to improve was nerve damage caused by diabetes. "Early, intensified intervention in type 2 diabetes patients with microalbuminuria with both target-driven pharmacological (medication) and behavioral actions increased life span. And, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Saxenda, Glipizide, Novolog, Januvia, Humalog, Glucophage, Bydureon, Invokana, Janumet, Trulicity, Glyburide, Byetta, Lantus Solostar, Levemir, Glimepiride

Diabetes Drug Victoza Might Not Help Advanced Heart Failure Patients

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – The diabetes drug liraglutide (Victoza) doesn't appear to improve heart function in patients with advanced heart failure, a new study finds. The theory for this trial was that this drug – from a class of medications called (GLP-1) agonists – might interact with the heart's GLP-1 receptors on cells and thereby improve heart function. "We were hoping for a benefit; we didn't see that. It's at best neutral," said lead researcher Dr. Kenneth Margulies. He's a professor of medicine and research director of heart failure and transplantation at the University of Pennsylvania in Philadelphia. Previous studies found evidence that people with advanced heart failure have insulin resistance of their peripheral muscles and heart muscle, and "this was felt to be a detrimental feature that this type of diabetes medicine might help," he said. Not only did the drug not help, ... Read more

Related support groups: Diabetes, Type 2, Victoza, Heart Failure, Congestive Heart Failure, Saxenda, Insulin Resistance, Pre-Diabetes, Liraglutide, Left Ventricular Dysfunction, Diabetes Mellitus, Abnormal Glucose Tolerance, Left Ventriculography

FDA OKs New Injectable Type 2 Diabetes Medication

Posted 28 Jul 2016 by Drugs.com

THURSDAY, July 28, 2016 – The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says. The once-daily injection is to be used along with diet and exercise to improve patients' blood sugar levels. The FDA reviewed 10 clinical trials on the safety and effectiveness of Adlyxin. These studies included 5,400 people with type 2 diabetes. The drug was also specifically tested for heart issues in an additional 6,000 people at risk of heart disease, the FDA said Thursday in a news release. The FDA concluded that Adlyxin helps normalize blood sugar levels. And it doesn't appear to increase the risk of heart problems. Adlyxin is in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Other GLP-1 drugs include liraglutide (Victoza), exenatide (Byetta, Bydureon) and dulaglutide (Trulicity), ... Read more

Related support groups: Diabetes, Type 2, Victoza, Saxenda, Insulin Resistance, Bydureon, Trulicity, Byetta, Pre-Diabetes, Liraglutide, Diabetes Mellitus, Abnormal Glucose Tolerance, Dulaglutide, Exenatide, Adlyxin, Lixisenatide

5 Diet Drugs: Which Ones Work?

Posted 14 Jun 2016 by Drugs.com

TUESDAY, June 14, 2016 – Any of the prescription weight-loss drugs on the market can help obese people shed pounds, although some seem more effective than others, a new study finds. Currently, five drugs are approved in the United States for managing obesity. But little has been known about how they stack up against one another, said Dr. Siddharth Singh, the lead researcher on the new study. The findings – based on more than 29,000 people in total – show all five drugs can work. But people on certain drugs tended to be more successful, at least over one year. Specifically, people using Qsymia (phentermine-topiramate) or Victoza (liraglutide) had the highest odds of shedding at least 5 percent of their initial weight. Those taking Xenical (orlistat) had the lowest odds. However, there is no single drug that's "best" for everyone, stressed Singh, an assistant clinical professor at the ... Read more

Related support groups: Obesity, Wellbutrin, Phentermine, Bupropion, Weight Loss, Contrave, Wellbutrin XL, Victoza, Belviq, Wellbutrin SR, Adipex-P, Naltrexone, Qsymia, Saxenda, Xenical, Orlistat, Alli, Zyban, Vivitrol, Liraglutide

Diabetes Drug Victoza May Help the Heart: Study

Posted 14 Jun 2016 by Drugs.com

TUESDAY, June 14, 2016 – The blood sugar-lowering drug Victoza (liraglutide) cuts the risk of heart attack and stroke in type 2 diabetes patients, a new study finds. Heart disease is the leading cause of death among people with type 2 diabetes, the researchers noted. The study was funded by the drug's maker, Novo Nordisk, and the U.S. National Institutes of Health. It included more than 9,300 adults from 32 countries who have type 2 diabetes and a high risk of heart disease. About half took Victoza, while the other half took an inactive placebo. Both groups also took other medications for health problems, such as high blood pressure and high cholesterol, the study authors said. Tracking patients for three years, the researchers found that compared with patients in the placebo group, people who took Victoza had a 13 percent lower risk of heart attack or stroke. They also had a 22 ... Read more

Related support groups: Ischemic Stroke, Heart Attack, Victoza, Saxenda, Transient Ischemic Attack, Myocardial Infarction, Liraglutide, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Myocardial Infarction - Prophylaxis

Cost of Insulin Rises Threefold in Just a Decade: Study

Posted 5 Apr 2016 by Drugs.com

TUESDAY, April 5, 2016 – Americans with diabetes who rely on insulin to keep their blood sugar levels in check are facing sticker shock: A new study finds the price of insulin has tripled in only 10 years. Moreover, since 2010, per-person spending on insulin in the United States was more than spending on all other diabetes drugs, the study found. "The cost of insulin has risen rapidly over the last few years," said study senior author Philip Clarke, a professor of health economics at the University of Melbourne in Australia. Clarke added there should be an assessment to see whether this price hike is justifiable in terms of improved clinical outcomes. One reason for the price climb, he said, is a switch from human insulins to analog insulins, which cost more but may offer additional benefits. Also, doctors are more apt to prescribe insulin for people with type 2 diabetes now, Clarke ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Saxenda, Diabetes, Type 1, Diabetic Neuropathy, Glipizide, Novolog, Januvia, Insulin Resistance, Humalog, Diabetic Nerve Damage, Glucophage, Bydureon, Invokana, Trulicity, Janumet, Glyburide

New Diabetes Cases Among Americans Drop for First Time in Decades: CDC

Posted 1 Dec 2015 by Drugs.com

TUESDAY, Dec. 1, 2015 – In a sign that Americans may finally be turning the corner in the fight against diabetes – and possibly obesity – federal health statistics released Tuesday show that the number of new cases of diabetes has dropped for the first time in decades. The decline wasn't sudden or dramatic. But, the number of new diabetes cases went from 1.7 million in 2009 to 1.4 million in 2014, according to the U.S. Centers for Disease Control and Prevention. "It seems pretty clear that incidence rates have now actually started to drop. Initially it was a little surprising because I had become so used to seeing increases everywhere we looked," CDC researcher Edward Gregg told The New York Times. The proportion of Americans with diabetes is still twice what it was in the early 1990s. And not every racial group has made strides against the blood sugar disease, which is often ... Read more

Related support groups: Obesity, Diabetes, Type 2, Metformin, Weight Loss, Insulin, Victoza, Lantus, Saxenda, Glipizide, Novolog, Januvia, Humalog, Glucophage, Bydureon, Invokana, Trulicity, Janumet, Glyburide, Byetta, Lantus Solostar

Too Many Seniors With Diabetes Are Overtreated, Study Suggests

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – When it comes to treating seniors with diabetes, new research suggests that doctors often don't cut back on medications, even when treatment goals are surpassed. The study found that when people had potentially dangerous low blood sugar levels, just 27 percent had their medicines decreased. And when blood pressure treatments lowered blood pressure levels too much, just 19 percent saw a reduction in their medications. "As people get older, the risks of overtreating become greater, and the benefits become shorter. We have to start emphasizing that more isn't always better," said study author Dr. Jeremy Sussman, an assistant professor of internal medicine at the University of Michigan in Ann Arbor and a primary care doctor at the Ann Arbor VA System. The findings were published online Oct. 26 in the journal JAMA Internal Medicine. Practice guidelines generally ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Saxenda, Glipizide, Novolog, Januvia, Humalog, Glucophage, Bydureon, Invokana, Trulicity, Janumet, Glyburide, Byetta, Lantus Solostar, Levemir, Actos

Diabetes Drug Might Also Help Some Patients Lose Weight

Posted 18 Aug 2015 by Drugs.com

TUESDAY, Aug. 18, 2015 – High doses of the diabetes drug liraglutide (Victoza) seem to help patients with type 2 diabetes lose weight, a new study suggests. In a trial funded by the drug's maker Novo Nordisk, people who took 3 milligrams (mg) of Victoza daily over 56 weeks lost an average of 6 percent of their body weight (14 pounds). According to Dr. Joel Zonszein, director of the Clinical Diabetes Center at Montefiore Medical Center in New York City, the U.S. Food and Drug Administration has approved the 3 mg-dose for weight loss, but not to treat diabetes. Only lower doses, either 1.2 mg or 1.8 mg a day, have the agency's blessing for treating type 2 diabetes. "This is the first study specifically designed to investigate the efficacy of liraglutide for weight management in patients with type 2 diabetes at a dose of 3 mg, and not surprisingly was found to be effective and tolerated ... Read more

Related support groups: Obesity, Diabetes, Type 2, Weight Loss, Victoza, Saxenda, Liraglutide

Health Tip: Diabetes Can Take a Toll on Teeth and Mouth

Posted 10 Aug 2015 by Drugs.com

-- Diabetes, especially when uncontrolled, can cause damage to your mouth and teeth. The Mouthhealthy.org website says possible effects of diabetes on the teeth and mouth include: Dry mouth, due to decreased saliva production. Increased risk of cavities due to less saliva. Gingivitis, characterized by bleeding, inflamed gums. Difficulty tasting food. Slower healing of mouth wounds. Increased risk of infection. Among diabetic children. teeth emerging earlier than expected. Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Oral and Dental Conditions, Xerostomia, Victoza, Toothache, Lantus, Saxenda, Diabetes, Type 1, Burning Mouth Syndrome, Diabetic Neuropathy, Glipizide, Novolog, Januvia, Insulin Resistance, Humalog, Diabetic Nerve Damage, Glucophage, Bydureon

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Weight Loss, Cardiovascular Risk Reduction, Diabetes, Type 2

Victoza Patient Information at Drugs.com